Medicine & Health
Updates every hour. Last Updated: 16-May-2025 13:09 ET (16-May-2025 17:09 GMT/UTC)
The skinny on fat, ascites and anti-tumor immunity
Ludwig Institute for Cancer ResearchPeer-Reviewed Publication
- Journal
- Science Immunology
- Funder
- Ludwig Institute for Cancer Research, Ludwig Center at Harvard, Irish Cancer Society, NIH/National Institutes of Health, Science Foundation Ireland, Ireland East Hospital Group, National Maternity Hospital Foundation, Glenn Foundation for Medical Research, American Association for Cancer Research, Company of Biologists
New film series 'The Deadly Five' highlights global animal infectious diseases
Biofaction (Austria)Business Announcement
- Funder
- Horizon Europe, HORIZON EUROPE Food
University Hospitals Seidman Cancer Center receives funding to implement improved symptom monitoring for patients undergoing cancer treatment
University Hospitals Cleveland Medical CenterGrant and Award Announcement
UH Seidman Cancer Center has been approved for funding by the Patient-Centered Outcomes Research Institute (PCORI) to implement electronic monitoring of patient’s self-reported symptoms during cancer treatment.
Led by Co-Principal Investigators Dr. Peter Pronovost, MD, PhD, UH Chief Quality and Clinical Transformation Officer, and Veale Distinguished Chair in Leadership and Clinical transformation and Melinda Hsu, MD, a medical oncologist at UH Seidman Cancer Center, this project aims to improve the quality of life and clinical outcomes for patients being treated for their cancer at UH Seidman Cancer Center by integrating electronic patient-reported outcome tools into EPIC, the electronic health record.
Fat-rich fluid fuels immune failure in ovarian cancer
Trinity College DublinPeer-Reviewed Publication
New research led by Irish scientists has uncovered how lipid-rich fluid in the abdomen, known as ascites, plays a central role in weakening the body’s immune response in advanced ovarian cancer. The findings offer new insights into immune suppression in ovarian cancer and open promising avenues for future immunotherapy approaches.
Over 70% of patients with ovarian cancer are diagnosed at an advanced stage, often presenting with large volumes of ascites. This ascites fluid not only supports the spread of cancer throughout the abdominal cavity but also significantly impairs the body’s immune defences. Understanding how ascites affects the immune system is important for developing better treatments that use the immune system to fight cancer.
In this recent study, researchers from Trinity College Dublin and University College Dublin explored how ascites disrupts immune cell function, with a particular focus on natural killer (NK) cells and T cells, which are key players in the body’s ability to eliminate tumours.
- Journal
- Science Immunology
- Funder
- Irish Cancer Society, NIH/National Institutes of Health, Research Ireland, Ireland East Hospital Group, National Maternity Hospital Foundation, Health Research Board, Ludwig Center at Harvard, Glenn Foundation for Medical Research, Gene Lay Institute, AACR Anna D. Barker Basic Cancer Research Fellowship
National Cancer Institute grant funds prostate cancer imaging study
Weill Cornell MedicineGrant and Award Announcement
Mass General Brigham researchers share tool to improve newborn genetic screening
Mass General BrighamPeer-Reviewed Publication
- Journal
- Genetics in Medicine